Definitive Contract 36C25722C0025
- Not listed
- Roche Diagnostics Corporation was awarded a $5.47 million firm fixed-price purchase order by Veterans Integrated Service Network 7 (VISN 7), a civilian component of the Department of Veterans Affairs, for COBAS 6800 cost per test kits. The contract, awarded on March 10, 2022, will be performed in Castleton, Indiana, with an ultimate completion date of March 9, 2027. This award does not utilize a set-aside designation and represents a child contract vehicle under Roche's broader federal...
- Roche Diagnostics Corporation has been awarded a blanket purchase agreement (BPA) call contract valued at approximately $969,000 by the Department of Veterans Affairs Veterans Health Administration (VA VHA) Veterans Integrated Service Network 22 (VISN 22). The contract is for infectious molecular pathology testing services on a cost-per-test basis to be performed at Roche's facility in Castleton, Indiana. It is anticipated that Roche will provide molecular diagnostic testing support for VISN...
- Roche Diagnostics Corporation was awarded a firm fixed price purchase order totaling four hundred twenty-eight thousand eighty-eight dollars and twelve cents ($428,088.12) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17. The contract has no set-aside designation. Roche will provide laboratory testing kits to support diagnostic testing needs at the Castleton, Indiana location. The award is associated with a special notice from the VA...
- Roche Diagnostics Corporation was awarded a delivery order valued at approximately $21.4 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2023. This firm fixed-price contract, with an ultimate completion date of November 28, 2025, will be performed in Castleton, Indiana. The delivery order was issued without a set-aside designation and is structured as a child contract under the General Services Administration's Critical Analyzers, Laboratory...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $608,837.85 firm fixed price delivery order to Roche Diagnostics Corporation for molecular pathology services. The contract does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided various medical equipment and supplies to federal agencies including the VA, Department of Defense, and Department of Health and Human Services through its General...
- Roche Diagnostics Corporation received a delivery order award valued at $294,964.39 for molecular pathology services from Veterans Integrated Service Network 12, a component of the Department of Veterans Affairs. This firm fixed-price contract, issued on April 1, 2025, with a completion date of September 30, 2025, represents a child order under a larger contract vehicle and carries no set-aside designation. The work will be performed in Castleton, Indiana. As a global leader in in vitro...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $1.12 million delivery order contract to Roche Diagnostics Corporation for the provision of molecular testing services. Specifically, Roche will provide cost per test for molecular testing to support the VA's response to the novel coronavirus pandemic. The firm fixed price contract runs from October 1, 2020 through January 31, 2022 and will be performed in Castleton, Indiana. No...
- Roche Diagnostics Corporation was awarded a $309,505.99 firm fixed-price Blanket Purchase Agreement (BPA) call by the Department of Veterans Affairs, Veterans Integrated Service Network 4, for molecular diagnostics reagents and tests. The contract, with a completion date of September 9, 2026, represents a call against the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule contract, which establishes pre-negotiated pricing and terms for diagnostic equipment and...
- Roche Diagnostics Corporation has been awarded a $866.67K delivery order by Veterans Integrated Service Network 20, a civilian component of the Department of Veterans Affairs, with a firm fixed-price structure. The contract covers laboratory reagents and consumables priced on a cost-per-reportable-result basis, with an ultimate completion date of February 10, 2026. The award represents a child contract under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration...
- The Department of Veterans Affairs (VA) awarded a $301,289.24 firm-fixed price purchase order to Roche Diagnostics Corporation for COBAS 6800/8800 SARS-COV-2 480T test kits and supplies. The 9-month base period runs from March 1, 2022 to August 1, 2024, with four 1-year option periods. This sole source award was made under the Simplified Procedures for Certain Commercial Items authority (FAR 13.5) and is not set-aside. The award will provide the VA's Gulf Coast Veterans Health Care System with...
Roche Diagnostics Corporation was awarded a definitive firm fixed-price contract valued at $2.51 million by the Department of Veterans Affairs Veterans Integrated Service Network 17, with performance through January 31, 2026. The contract, awarded January 1, 2022, provides molecular testing support and maintenance services for the Roche Cobas 6800 system at the Doris Miller VA Medical Center in Waco, Texas. The award was issued without a set-aside designation following a Special Notice solicitation published in October 2021 that identified the services as proprietary to Roche, with no alternative suppliers available to meet the VA's requirements for viral load and molecular testing capabilities. Under this contract, Roche Diagnostics supplies test kits, reagents, consumable materials, training, and maintenance support necessary for the operation and performance of the Cobas 6800 molecular testing system. The Special Notice indicated the initial contract term spans one year with four optional one-year extension periods available. This award reflects the VA's continued reliance on Roche's diagnostic technologies across its integrated service networks, supporting the agency's laboratory testing operations for disease detection and patient care delivery within the veteran healthcare system.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6550--NEW - CTX MOLECULAR TESTING | 36C25722Q0011 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Special Notice 1/1 | 10/5/21, 2:52 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00012 | Exercise an Option | $677.2k | 11/18/25 | |
| P00011 | Supplemental Agreement for work within scope | $0 | 7/14/25 | |
| P00010 | Supplemental Agreement for work within scope | ($97k) | 7/14/25 | |
| P00009 | Supplemental Agreement for work within scope | ($477k) | 2/13/25 | |
| P00008 | Exercise an Option | $774.2k | 10/8/24 |